Tumor Homing Reactive Oxygen Species Nanoparticle for Enhanced Cancer Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Hyeon-Yeol | - |
dc.contributor.author | Mavi, Ahmet | - |
dc.contributor.author | Chueng, Sy-Tsong Dean | - |
dc.contributor.author | Pongkulapa, Thanapat | - |
dc.contributor.author | Pasquale, Nicholas | - |
dc.contributor.author | Rabie, Hudifah | - |
dc.contributor.author | Han, Jiyou | - |
dc.contributor.author | Kim, Jong Hoon | - |
dc.contributor.author | Kim, Tae-Hyung | - |
dc.contributor.author | Choi, Jeong-Woo | - |
dc.contributor.author | Lee, Ki-Bum | - |
dc.date.available | 2019-08-13T05:56:36Z | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 1944-8244 | - |
dc.identifier.issn | 1944-8252 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/33068 | - |
dc.description.abstract | Multifunctional nanoparticles that carry chemotherapeutic agents can be innovative anticancer therapeutic options owing to their tumor-targeting ability and high drug-loading capacity. However, the nonspecific release of toxic DNA-intercalating anticancer drugs from the nanoparticles has significant side effects on healthy cells surrounding the tumors. Herein, we report a tumor homing reactive oxygen species nanoparticle (THoR-NP) platform that is highly effective and selective for ablating malignant tumors. Sodium nitroprusside (SNP) and diethyldithiocarbamate (DDC) were selected as an exogenous reactive oxygen species (ROS) generator and a superoxide dismutase 1 inhibitor, respectively. DDC-loaded THoR-NP, in combination with SNP treatment, eliminated multiple cancer cell lines effectively by the generation of peroxynitrite in the cells (>95% cell death), as compared to control drug treatments of the same concentration of DDC or SNP alone (0% cell death). Moreover, the magnetic core (ZnFe2O4) of the THoR-NP can specifically ablate tumor cells (breast cancer cells) via magnetic hyperthermia, in conjunction with DDC, even in the absence of any exogenous RS supplements. Finally, by incorporating iRGD peptide moieties in the THoR-NP, integrin-enriched cancer cells (malignant tumors, MDA-MB-231) were effectively and selectively killed, as opposed to nonmetastatic tumors (MCF-7), as confirmed in a mouse xenograft model. Hence, our strategy of using nanoparticles embedded with ROS-scavenger-inhibitor with an exogenous ROS supplement is highly selective and effective cancer therapy. © 2019 American Chemical Society. | - |
dc.format.extent | 19 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | American Chemical Society | - |
dc.title | Tumor Homing Reactive Oxygen Species Nanoparticle for Enhanced Cancer Therapy | - |
dc.type | Article | - |
dc.identifier.doi | 10.1021/acsami.9b07483 | - |
dc.identifier.bibliographicCitation | ACS Applied Materials and Interfaces, v.11, no.27, pp 23900 - 23918 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000475532200011 | - |
dc.identifier.scopusid | 2-s2.0-85068416069 | - |
dc.citation.endPage | 23918 | - |
dc.citation.number | 27 | - |
dc.citation.startPage | 23900 | - |
dc.citation.title | ACS Applied Materials and Interfaces | - |
dc.citation.volume | 11 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | cancer therapy | - |
dc.subject.keywordAuthor | magnetic core-shell nanoparticles | - |
dc.subject.keywordAuthor | nanotechnology | - |
dc.subject.keywordAuthor | reactive species | - |
dc.subject.keywordAuthor | tumor targeting | - |
dc.subject.keywordPlus | Cell culture | - |
dc.subject.keywordPlus | Cell death | - |
dc.subject.keywordPlus | Controlled drug delivery | - |
dc.subject.keywordPlus | Core shell nanoparticles | - |
dc.subject.keywordPlus | Diseases | - |
dc.subject.keywordPlus | Drug interactions | - |
dc.subject.keywordPlus | Enzymes | - |
dc.subject.keywordPlus | Holmium compounds | - |
dc.subject.keywordPlus | Iron compounds | - |
dc.subject.keywordPlus | Magnetic cores | - |
dc.subject.keywordPlus | Nanomagnetics | - |
dc.subject.keywordPlus | Nanoparticles | - |
dc.subject.keywordPlus | Nanotechnology | - |
dc.subject.keywordPlus | Oncology | - |
dc.subject.keywordPlus | Oxygen | - |
dc.subject.keywordPlus | Tumors | - |
dc.subject.keywordPlus | Zinc compounds | - |
dc.subject.keywordPlus | Cancer therapy | - |
dc.subject.keywordPlus | Chemotherapeutic agents | - |
dc.subject.keywordPlus | Diethyldithiocarbamate | - |
dc.subject.keywordPlus | Multi-functional nanoparticles | - |
dc.subject.keywordPlus | Reactive oxygen species | - |
dc.subject.keywordPlus | Reactive species | - |
dc.subject.keywordPlus | Super oxide dismutase | - |
dc.subject.keywordPlus | Tumor targeting | - |
dc.subject.keywordPlus | Targeted drug delivery | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.